Lymphocyte-to-segmentonuclear neutrophil ratio in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
Activity of lysozyme in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
The profile of patients with pulmonary and extrapulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Factors associated with sputum culture conversion in patients with pulmonary tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Cytokines/chemokines gene expression in the lungs of fibrous-cavernous TB patients. Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
Endobrochites of specific genesis in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004
Intestinal parasiroses in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
Frequency of endobronchial tuberculosis in patients with active pulmonary tuberculosis is high Source: Eur Respir J 2004; 24: Suppl. 48, 33s Year: 2004
Levels of IL-1β and TNFα production in patients with lung tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002
Autoantibodies in patients treated for active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
A comparative study on serum ADA levels in cavitary and non-cavitary pulmonary tuberculosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Lung function in patients cured for pulmonary tuberculosis Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 6s Year: 2006
Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Ca 125 in the differential diagnosis of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006